Graduate Student
Entry into the Program: Fall 2025
Pronouns: She/Her
Advising Professor(s): Dr. Tyler Varisco
Education
- Doctor of Pharmacy (Pharm.D.), Tehran University of Medical Sciences
Research Interests
- Cancer Research, Heath Services Research, Opioid Use Disorder
Publications
- Bahar Mostafiz, Sara Arjomand Bigdeli, Kamran Banan, Hanif Afsharara, Dara Hatamabadi, Parasto Mousavi,“Molecularly imprinted polymer-carbon paste electrode (MIP-CPE)-based sensors for the sensitive detection of organic and inorganic environmental pollutants: A review,” Trends in environmental analytical chemistry, 32(e00144), p. e00144.
- Erfan Asadipour, Mahtab Asgari, Parasto Mousavi, Tohid Piri Gharaghie, Ghazal Ghajari “Nano-biotechnology and challenges of drug delivery system in cancer treatment pathway: Review article,” Chemistry & biodiversity.
- Parasto Mousavi, Sahar Yazdanfard, Sujit Sansgiry, Tyler Varisco “The Impact of Time Delays between Breast Cancer Diagnosis and Surgery on Overall Survival: A Retrospective Analysis in the Texas Cancer Registry” Recently under review, Frontiers for Oncology.
- Parasto Mousavi, Zahra Jahangard Rafsanjani, Amirhossein Emami “The compliance of antiemetic regimens used with the international guidelines in patients with cancer receiving chemotherapy” Submitted at Clinical Oncology journal.
- Bilqees Fatima, Phillip Shayne Pruneda, Parasto Mousavi, Rheena Sheriff, Ronnie Ozuna, Meghana V. Trivedi, Susan Abughosh “Group-Based Trajectory Model to Assess Adjuvant Endocrine Therapy Adherence Pattern in HR-positive Breast Cancer: Results from Rio Grande Valley Patients” Under review, Healthcare.
- Parasto Mousavi, Rudi Safarudin, Tyler Varisco “The impact of opioid use prior to pancreatic cancer diagnosis on overall survival: Insights from SEER-Medicare data.” Journal of Clinical Oncology.
Presentations
- Parasto Mousavi, Sahar Yazdanfard, Tyler Varisco “The Impact of Time Delays between Breast Cancer Diagnosis and Surgery on Overall Survival: A Retrospective Analysis in the Texas Cancer Registry”, AMCP Nexus 2024
- Parasto Mousavi, Tyler Varisco “Evaluating the Utility of PHQ-9 for Depression Screening and Its Influence on Clinical Decisions in Sickle Cell Patients”, Academy Health 2025
- Parasto Mousavi, Zahra Jahangard Rafsanjani “The compliance of antiemetic regimens used with the international guidelines in patients with cancer receiving chemotherapy”, European Conference of Oncology Pharmacy (ECOP) 2022
- Parasto Mousavi, Rudi Safarudin, Tyler Varisco “The impact of opioid use prior to pancreatic cancer diagnosis on overall survival: Insights from SEER-Medicare data.”, American Society of Clinical Oncology (ASCO) 2025.
- Parasto Mousavi, Tyler Varisco, Virginia Mohlere and Muhammad B Abid “Non-relapse mortality and immune-related adverse events with lifileucel: a post-marketing surveillance analysis” Submitted at Society for Immunotherapy of Cancer (SITC) 2025.
Contact Information
Why UTCOP HOD?
- I chose the UT College of Pharmacy Health Outcomes Division because of its strong foundation in real-world evidence generation, Pharmacoeconomics, and patient-centered outcomes research Importantly, the Division—through its Texas Center for Health Outcomes Research and Education (TxCORE), leverages high-quality population-level cancer data, including SEER-linked registries, to support rigorous outcomes research. As someone passionate about cancer outcomes, I'm excited by the opportunity to develop skills using these data resources and to contribute to studies that inform oncology care and policy.
What do you enjoy outside of school?
- Outside of school, I enjoy creative writing, deep conversations with friends, and exploring different cultures, especially through food.